Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro (tirzepatide) can be injected at any time of day, with or without food. Unlike some oral medicines, its absorption through the skin is not meaningfully affected by meals — the Mounjaro SmPC on the eMC confirms there are no food-related restrictions on when you inject. That said, the timing choices you make can still influence how comfortable you feel, and that nuance is worth understanding properly before you settle into a weekly routine.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The reason the food question matters less than it might seem lies in how tirzepatide enters your body. Oral medicines absorbed through the gut lining can be slowed, diluted or chemically altered by a meal. Mounjaro bypasses all of that: it is injected directly into the fatty tissue beneath the skin (the abdomen, thigh or upper arm) and moves from there into the bloodstream without passing through the digestive process at all. The Mounjaro Summary of Product Characteristics (eMC) includes no food-related instruction because none is clinically necessary.
This is also why Mounjaro's once-weekly schedule works the way it does. Rather than needing to be taken at a precise moment in your eating day, the medicine accumulates in your system over the week and acts continuously (on appetite signalling, gastric emptying rate and blood-sugar regulation) regardless of whether you last ate an hour ago or this morning. Consistency in the day of the week is what the prescriber sets; whether that falls before or after dinner is entirely your call.
So if timing is clinically flexible, why do so many people ask about it? Because the early weeks of treatment can bring gastrointestinal side effects (nausea, indigestion, a feeling of fullness that arrives quickly) and it is natural to wonder whether the injection is better paired with food or taken on an empty stomach. The NHS tirzepatide page notes that nausea is among the most commonly reported effects, particularly after starting treatment or stepping up to a higher dose, and that it usually settles over the following days to two weeks.
Some people find that injecting shortly after a light meal (rather than on an empty stomach) reduces the sharpness of early nausea. Others notice no difference. Neither approach is medically superior; both are consistent with the licence. If you are mid-treatment and finding side effects hard to manage, that is a conversation for your prescriber, not a reason to change injection timing independently. The pattern worth keeping is the same day each week, whatever time suits you.
One practical note from people who manage this well: tying the injection to a regular weekly marker (after Saturday lunch, say, or the same evening you do a food shop) makes it harder to forget and easier to track in the pen's dose window. If you are also thinking about what happens to unused doses after 30 days, that page covers the storage and expiry guidance in detail.
The food-timing question sits firmly in the comfortable territory. The eligibility question is where the clinical weight falls. Mounjaro is a prescription-only medicine licensed for weight management in adults with a BMI of 30 or above, or 27 or above with at least one weight-related condition such as high blood pressure, type 2 diabetes or obstructive sleep apnoea. BMI alone does not guarantee a prescription, the prescriber looks at the whole picture, including your medical history and any medicines you already take. For a thorough breakdown of the thresholds, the BMI criteria for Mounjaro page works through the numbers clearly.
If you are wondering whether you qualify at all, who can take Mounjaro covers the full licensed criteria, including the conditions that affect suitability. And if your situation involves a previous bariatric procedure, there are specific considerations, including whether Mounjaro is appropriate following surgery more broadly, and the guidance for people who have had a gastric sleeve sets those out separately.
Cost context is something many readers check at this point. Treatment pricing varies by dose and provider; if you want to understand what the private market looks like and what a legitimate price actually includes, the Mounjaro cost context page addresses that directly without steering you toward any particular number.
At nume, every consultation is read by a GPhC-registered Independent Prescriber, a real clinician, not a decision tree. Once approved, treatment is dispatched the same day if you order before noon, and delivered free the next working day by DPD in plain packaging. There are no subscriptions and no hidden costs: the price you see covers the consultation, the prescription, the treatment and aftercare seven days a week. Every repeat order is clinically re-reviewed before it goes out.
If you have questions about whether your situation is suitable before you begin, our frequently asked questions cover the common ones, or you can read more about our clinical team on the prescriber profile page. When you are ready, start your free consultation and a prescriber will review your answers the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.